Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Taiwan has become a preferred destination for clinical trials due to its growing market for drug development, expanding population, and comprehensive healthcare system. The rising biopharmaceutical industry in the country is expected to boost market growth.
The demand for bioanalytical services is often tied to the growth of the biopharmaceutical industry. Biomedicine holds significant importance for Taiwan, as the government strives to establish the country as a premier hub for biomedical R&D in the Asia-Pacific region.
The objective by 2025 is to develop twenty new medicines, initiate 80 high-value medical devices to the market, and propel the biomedicine industry into a trillion-NT-dollar (approximately USD 32 billion) sector.
Horizon Databook provides a detailed overview of country-level data and insights on the Taiwan bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Taiwan bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account